Unlock more critical insights faster

Leverage diverse global data assets on disease spread, outbreak suitability, population vulnerability, and more to make high-stakes decisions with confidence. with confidence.

Everything you need in one place

When a fast-moving outbreak appears, you need to have all your critical data and tools ready to go. Our trusted global library of data means you’ll have always-on access to the highest quality, cleaned, documented, structured, and API accessible data to generate rapid, high-quality risk assessments.

Be ready for any type of threat

With outbreaks, you never know which microbe you might face next. And every microbe behaves differently. But with our library of diverse data assets spanning pathogen, population, and environmental drivers, you’ll be capable of rapidly generating critical insights regardless of whether you’re facing a highly contagious respiratory disease, viral hemorrhagic fever, vector-borne or other high-consequence infectious disease.

Extend the knowledge of your team

Understanding infectious disease risk is a complex endeavor. It takes infectious disease experts, physicians, veterinarians, public health experts, epidemiologists, data scientists and more. At BlueDot, our in-house experts continuously maintain our risk analysis toolkit, incorporating expert-written forecasts, in-depth regional trends, and meticulous analysis of emerging and relevant risks to be aware of.

"One of the benefits we get from BlueDot is quantifying what our risk is. BlueDot informed decisions around advising some of our international stations to spruce up our screening protocol for passengers coming into Brussels from Congo. We were looking at taking those measures where we felt there was more exposure to our operations.”

Joseph Bajzath,
Sr. Director of Corporate Safety and Emergency Management, Air Canada

Global forces from urbanization to climate change and international travel are rapidly accelerating infectious disease emergence, spread, and disruption

0 %

increase in animal-to-human transmission of influenza viruses in 2021 compared to the year prior

0 days

for Mpox to spread from West Africa to Europe

0 km

projected northward expansion of disease-carrying Aedes albopictus mosquitoes to Europe by 2032

Get critical insights faster so you can respond sooner

Book a demo today.